Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6829890 | 0.91 | TK2 (0.34) | TK2TK1 | |
| SCHEMBL6830095 | 0.86 | TK2 (0.35) | TK2TK1 | |
| SCHEMBL6827472 | 0.85 | TK1 (0.32) | TK2TK1 | |
| SCHEMBL7156616 | 0.83 | TK2 (0.31) | TK2TK1 | |
| SCHEMBL6830082 | 0.80 | TK1 (0.39) | TK2TK1 | |
| SCHEMBL1096963 | 0.79 | TK2 (0.32) | TK2TK1 | |
| SCHEMBL6827481 | 0.79 | RNASE1 (0.36) | TK1 | |
| SCHEMBL1097588 | 0.78 | TYMP (0.32) | TK2TK1 | |
| SCHEMBL22984007 | 0.78 | RNASE1 (0.40) | TK2TK1 | |
| SCHEMBL9550769 | 0.78 | RNASE1 (0.40) | TK2TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6743902-B1 | FOR USE IN ANTISENSE THERAPY FOR ENHANCING NUCLEASE RESISTANCE AND CELLULAR UPTAKE | VALEANT PHARMACEUTICALS INTERNATIONAL | 2004-06-01 | — | — | US | disclosed |
| US-6191266-B1 | MODIFIED TO COMPRISE SUBSTITUTIONS AT POSITIONS C1', C3', C4' OR C5' OF THE SUGAR MOIETY OF THE NUCLEOSIDE, INCLUDING AN OPTIONAL 3' PHOSPHOROAMIDITE GROUP; USE IN MAKING NUCLEASE RESISTANT OLIGONUCLEOTIDES FOR ANTISENSE THERAPY | ICN PHARMACEUTICALS, INC. | 2001-02-20 | — | — | US | disclosed |
| US-5712378-A | SUGAR MOLECULE IS SUBSTITUTED WITH HYDROCARBON OR SUBSTITUTED HYDROCARBON GROUPS, ANTISENSE AGENTS | ICN PHARMACEUTICALS (US) | 1998-01-27 | — | — | US | disclosed |